Antibody Reduces Allergic Reactions to Multiple Foods in NIH Clinical Trial

February 25, 2024 -- A 16-week course of a monoclonal antibody, omalizumab, increased the amount of peanut, tree nuts, egg, milk and wheat that multi-food allergic children as young as 1 year could consume without an allergic reaction in a...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials